MONTREAL, QUEBEC -- (MARKET WIRE) -- December 18, 2006 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it received confirmation from Le Ministere du Revenu du Quebec that its common shares qualify for the SME Growth Plan and are registered by the Autorite des Marches Financiers.
